Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 1:19 AM
NCT ID:
NCT04730193
Eligibility Criteria:
Inclusion Criteria:
* English speaking
* Ability to read and write in English
* Competence to provide informed consent
* Non-occludable angle and with no optic neuropathy
* Subjects will be asked to refrain from caffeine consumption for at least 8 hours before participating in the study
Exclusion Criteria:
* The history of photosensitive epilepsy
* Intraocular pressure 21 Hgmm or higher
* Eyes with a visual acuity 20/30 or lower or the inability to fixate on fixation markers
* Previous symptoms of glaucoma attack (severe ocular pain and redness, decreased vision, colored halos in combination with headache, nausea and vomiting).
* Known allergies to study drugs
* Pregnancy and breast feeding
* Significant cardiac disease (e.g. heart failure), chest pain in the last 6 months
* Stage-2 high blood pressure not controlled by medication (\>160/100 mm Hg)
* Uncontrolled diabetes mellitus; History of stroke; Multiple sclerosis; Chronic obstructive pulmonary disease; Active cancer; Abnormal liver function
* Diagnosis of dementia; Anxiety Disorder
* Absent temporal acoustic windows, intracranial stenosis (for TCD-related studies)
* History of arrhythmias
* Prisoners
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
85 Years
Study:
NCT04730193
Study Brief:
Protocol Section:
NCT04730193